001065.KS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 06:00):

JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others...

Stats
Dzisiejszy wolumen	47.00
Średni wolumen	231.00
Kapitalizacja rynkowa	703.60B
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW0 (0.00%)

JW Pharmaceutical Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

JW Pharmaceutical Finanse

Annual	2023
Przychody:	KRW748.53B
Zysk brutto:	KRW335.67B (44.84 %)
EPS:	KRW1 503.91

FY	2023
Przychody:	KRW748.53B
Zysk brutto:	KRW335.67B (44.84 %)
EPS:	KRW1 503.91

FY	2022
Przychody:	KRW684.35B
Zysk brutto:	KRW287.95B (42.08 %)
EPS:	KRW1 267.10

FY	2021
Przychody:	KRW606.58B
Zysk brutto:	KRW234.38B (38.64 %)
EPS:	KRW-9.23

Financial Reports:

No articles found.

JW Pharmaceutical